Evidence map›Paper›PMID 19904943›Full record

ArticleJournal of the American Chemical Society2009

Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies.

Sailaja Arungundram, Kanar Al-Mafraji, Jinkeng Asong, Franklin E Leach, I Jonathan Amster, Andre Venot, Jeremy E Turnbull, Geert-Jan Boons

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 116 papers.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 264 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Chemical Synthesis of Oligosaccharides Derived fromJournal of the American Chemical Society · 2025
    Article
  6. Review
  7. Article
  8. Untangling Heparan Sulfate 3-Analytical chemistry · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Synthetic Heparanase Inhibitors Can Prevent Herpes Simplex Viral Spread.Angewandte Chemie (International ed. in English) · 2023
    Article
  14. Article
  15. Article
  16. Recent Advances in Chemical Synthesis of Amino Sugars.Molecules (Basel, Switzerland) · 2023
    Review
  17. Article
  18. Article
  19. Heparan sulfate glycomimeticsChemical science · 2023
    Article
  20. Article

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Sailaja ArungundramComplex Carbohydrate Research Center, University of Georgia, 315 Riverbend Road, Athens, Georgia 30602, USA.
Kanar Al-Mafraji
Jinkeng Asong
Franklin E Leach
I Jonathan Amster
Andre Venot
Jeremy E Turnbull
Geert-Jan Boons
University of Liverpool · GBUniversity of Georgia · US

Funding

ZINC DEFICIENCY &PROTEIN EXPRESSION IN RAT OLFACTORY BULBSP41RR005351 · NCRR · UNIVERSITY OF GEORGIA (UGA) · PI VENOT, ANDRE · 1989 to 2011
$18.4M
TR&D3. Approaches to Proteoglycan Function at Biochemical and Cellular LevelsP41GM103390 · NIGMS · UNIVERSITY OF GEORGIA · PI MOREMEN, KELLEY W. · 2012 to 2019
$14.5M
Biotechnology and Biological Sciences Research Council BBS/B/13047Medical Research Council G117/423NCRR NIH HHS 2 P41 RR005351NCRR NIH HHS P41 RR005351NIGMS NIH HHS P41 GM103390
6 · The paper itself

Abstract

Although hundreds of heparan sulfate binding proteins have been identified and implicated in a myriad of physiological and pathological processes, very little information is known about the ligand requirements for binding and mediating biological activities by these proteins. This difficulty results from a lack of technology for establishing structure-activity relationships, which in turn is due to the structural complexity of natural heparan sulfate (HS) and difficulties of preparing well-defined HS oligosaccharides. To address this deficiency, we developed a modular approach for the parallel combinatorial synthesis of HS oligosaccharides that utilizes a relatively small number of selectively protected disaccharide building blocks, which can easily be converted into glycosyl donors and acceptors. The utility of the modular building blocks has been demonstrated by the preparation of a library of 12 oligosaccharides, which has been employed to probe the structural features of HS for inhibiting the protease, BACE-1. The complex variations in activity with structural changes support the view that important functional information is embedded in HS sequences. Furthermore, the most active derivative provides an attractive lead compound for the preparation of more potent compounds, which may find use as a therapeutic agent for Alzheimer's disease.

Indexed as

Carbohydrate SequenceHeparan SulfateMolecular Sequence DataStructure-Activity RelationshipHeparan Sulfate

Identifiers

PMID19904943
PMCPMC2820250
OpenAlexW2078754833

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.